Northland analyst Tim Savageaux lowered the firm’s price target on Viavi to $13 from $15 and keeps an Outperform rating on the shares after the company issued "a rather tardy" downside pre-announcement for fiscal Q3, citing lab test weakness among networking and component OEMs. In the medium-term, the firm sees catalysts for resumed Communications Test growth in "a strong cable networking upgrade cycle," the analyst tells investors.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VIAV:
- Viavi price target lowered to $11 from $13.50 at B. Riley
- Viavi price target lowered to $14 from $16 at Susquehanna
- VIAVI Announces Preliminary Financial Results and Reporting Date for Fiscal Third Quarter 2023
- Viavi lowers Q3 revenue view to $246M-$248M from $256M-$276M, consensus $269.48M
- Viavi announces AVX-10K Flight Line Test Set approved for use on Boeing aircraft
